CONCORD BIOTECH
Back to Income Statement
|
CONCORD BIOTECH Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹308 Cr | ₹240 Cr | ₹17 Cr | ₹235 Cr | ₹1,690 Cr |
What is the latest Consolidated Net Profit of CONCORD BIOTECH ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹308 Cr |
| Mar2024 | ₹240 Cr |
| Mar2023 | ₹17 Cr |
| Mar2022 | ₹235 Cr |
| Mar2021 | ₹1,690 Cr |
How is Consolidated Net Profit of CONCORD BIOTECH Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹308 Cr | 28.33 | |
| Mar2024 | ₹240 Cr | 1,272.47 | |
| Mar2023 | ₹17 Cr | -92.55 | |
| Mar2022 | ₹235 Cr | -86.10 | |
| Mar2021 | ₹1,690 Cr | - | |
Compare Consolidated Net Profit of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹10,731.4 Cr | -1.3% | -16% | -38.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -1.3% |
-16% |
-38.4% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses